Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus
- PMID: 40312552
- PMCID: PMC12046011
- DOI: 10.1038/s41598-025-98991-0
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus
Abstract
Inflammatory bowel disease (IBD) is an autoimmune disease (AD) characterized by chronic, relapsing intestinal inflammation. Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multisystem involvement and overactivation of both innate and adaptive immunity. The extra intestinal manifestations (EIMs) that commonly occur in IBD include many of the organ sites that are affected by SLE. ADs are often comorbid with one another and may have shared underlying genetic features and architectures contributing to their pathogenesis and disease course. We performed both epidemiological and post-genome wide association study (GWAS) analyses to investigate the shared genetic features between IBD and systemic lupus erythematosus (SLE). Specifically, we performed epidemiological association analysis in the All of Us Research Program (AoURP) and genome-wide/local genetic correlation analysis and cell-type specific SNP heritability enrichment analysis using previously published summary level data. A significant epidemiologic association exists between IBD and SLE with an adjusted odds ratio (aOR) of 2.94 (95% CI: 2.45-3.53; P < 0.001) in a multivariable model accounting for confounders in the AoURP data. Genome-wide genetic correlation analysis in previously published summary level data demonstrated a significant genetic correlation between IBD, CD, and UC with SLE, and local genetic correlation analysis demonstrated several positive and significant correlations in local genomic regions harboring disease variants in genes common to both SLE and IBD etiology, including variants in ELF1, CD226, JAZF1, WDFY4, and JAK2. Cell-type SNP heritability enrichment analysis identified both overlapping and distinct functional categories contributing to SNP heritability across IBD phenotypes. Notably, IBD-related phenotypes demonstrated significant enrichment in T-lymphocyte functional groups while SLE signal appeared in distinct categories, such as B-lymphocytes (along with CD). Gene-level collapsing analysis of rare variants in the United Kingdom BioBank (UKBB) identified overlapping nominally-significant genes between SLE and IBD, CD, and UC. By leveraging several post-GWAS methods, the present study identifies shared genetic features between IBD and SLE, highlighting similarities and differences in the genetic features that contribute to the pathogenesis of each disease.
Keywords: Autoimmune disease; Inflammatory bowel disease; Systemic lupus erythematosus.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: Jeffrey M. Cohen (JMC) serves on a data and safety monitoring board for Advarra and has served as a consultant for Novartis and Takeda. The other authors have no competing interests to declare.
Figures


Update of
-
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus.Res Sq [Preprint]. 2025 Mar 28:rs.3.rs-5804830. doi: 10.21203/rs.3.rs-5804830/v1. Res Sq. 2025. Update in: Sci Rep. 2025 May 1;15(1):15309. doi: 10.1038/s41598-025-98991-0. PMID: 40196008 Free PMC article. Updated. Preprint.
Similar articles
-
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus.Res Sq [Preprint]. 2025 Mar 28:rs.3.rs-5804830. doi: 10.21203/rs.3.rs-5804830/v1. Res Sq. 2025. Update in: Sci Rep. 2025 May 1;15(1):15309. doi: 10.1038/s41598-025-98991-0. PMID: 40196008 Free PMC article. Updated. Preprint.
-
Investigating the shared genetic basis of inflammatory bowel disease and systemic lupus erythematosus using genetic overlap analysis.BMC Genomics. 2024 Sep 16;25(1):868. doi: 10.1186/s12864-024-10787-0. BMC Genomics. 2024. PMID: 39285290 Free PMC article.
-
Association between systemic lupus erythematosus and inflammatory bowel disease in European and East Asian populations: a two-sample Mendelian randomization study.Front Immunol. 2023 Nov 3;14:1199896. doi: 10.3389/fimmu.2023.1199896. eCollection 2023. Front Immunol. 2023. PMID: 38022503 Free PMC article.
-
Recent advances in understanding the genetic basis of systemic lupus erythematosus.Semin Immunopathol. 2022 Jan;44(1):29-46. doi: 10.1007/s00281-021-00900-w. Epub 2021 Nov 3. Semin Immunopathol. 2022. PMID: 34731289 Review.
-
Genomics of Systemic Lupus Erythematosus: Insights Gained by Studying Monogenic Young-Onset Systemic Lupus Erythematosus.Rheum Dis Clin North Am. 2017 Aug;43(3):415-434. doi: 10.1016/j.rdc.2017.04.005. Rheum Dis Clin North Am. 2017. PMID: 28711143 Review.
References
-
- Baumgart, D. C. & Sandborn, W. J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet369 (9573), 1641–1657. 10.1016/S0140-6736(07)60751-X (2007). - PubMed
-
- Ananthakrishnan, A. N. et al. Environmental triggers in IBD: a review of progress and evidence. Nat. Rev. Gastroenterol. Hepatol.15 (1), 39–49. 10.1038/nrgastro.2017.136 (2018). - PubMed
-
- Fang, Y. et al. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: opportunities and challenges. Autoimmun. Rev.22 (3), 103260. 10.1016/j.autrev.2022.103260 (2023). - PubMed
MeSH terms
Grants and funding
- OT2 OD026556/OD/NIH HHS/United States
- U2C OD023196/OD/NIH HHS/United States
- OT2 OD025315/OD/NIH HHS/United States
- U24 OD023121/OD/NIH HHS/United States
- OT2 OD026552/OD/NIH HHS/United States
- OT2 OD026549/OD/NIH HHS/United States
- OT2 OD025337/OD/NIH HHS/United States
- OT2 OD026555/OD/NIH HHS/United States
- OT2 OD026550/OD/NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
- OT2 OD023205/OD/NIH HHS/United States
- OT2 OD025276/OD/NIH HHS/United States
- OT2 OD026557/OD/NIH HHS/United States
- OT2 OD026554/OD/NIH HHS/United States
- U24 OD023163/OD/NIH HHS/United States
- OT2 OD023206/OD/NIH HHS/United States
- U24 OD023176/OD/NIH HHS/United States
- OT2 OD026548/OD/NIH HHS/United States
- ES030285/NH/NIH HHS/United States
- OT2 OD026551/OD/NIH HHS/United States
- P30 ES030285/ES/NIEHS NIH HHS/United States
- OT2 OD025277/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous